SEB Asset Management AB Purchases Shares of 24,528 Privia Health Group, Inc. $PRVA

SEB Asset Management AB acquired a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 24,528 shares of the company’s stock, valued at approximately $505,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Bayban bought a new position in shares of Privia Health Group in the fourth quarter valued at about $26,000. Hantz Financial Services Inc. boosted its holdings in shares of Privia Health Group by 456.2% during the 4th quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after buying an additional 926 shares during the period. Global Retirement Partners LLC boosted its holdings in shares of Privia Health Group by 579.8% during the 4th quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock worth $38,000 after buying an additional 1,351 shares during the period. Canada Pension Plan Investment Board grew its stake in Privia Health Group by 48.0% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after buying an additional 1,200 shares during the last quarter. Finally, Kestra Advisory Services LLC acquired a new position in Privia Health Group in the 4th quarter valued at about $93,000. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Citigroup restated a “buy” rating on shares of Privia Health Group in a research report on Thursday. Evercore set a $26.00 target price on Privia Health Group in a research report on Wednesday, April 8th. Barclays decreased their target price on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 26th. Zacks Research cut Privia Health Group from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 7th. Finally, Canaccord Genuity Group reduced their price target on Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, May 8th. Eleven research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Privia Health Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $31.15.

Privia Health Group Stock Up 2.1%

NASDAQ PRVA opened at $25.50 on Friday. The company has a market capitalization of $3.21 billion, a P/E ratio of 159.38, a P/E/G ratio of 1.98 and a beta of 0.83. Privia Health Group, Inc. has a 12-month low of $18.77 and a 12-month high of $28.82. The firm has a 50-day moving average price of $24.40 and a two-hundred day moving average price of $23.34.

Insider Transactions at Privia Health Group

In related news, CFO David Mountcastle sold 24,734 shares of the business’s stock in a transaction that occurred on Thursday, July 2nd. The stock was sold at an average price of $27.50, for a total value of $680,185.00. Following the completion of the sale, the chief financial officer directly owned 186,728 shares in the company, valued at approximately $5,135,020. The trade was a 11.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Parth Mehrotra sold 105,439 shares of the stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $22.55, for a total value of $2,377,649.45. Following the sale, the chief executive officer directly owned 450,004 shares in the company, valued at $10,147,590.20. This represents a 18.98% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 478,855 shares of company stock valued at $12,099,109. 5.70% of the stock is currently owned by company insiders.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.